New Products

Aug 29, 2018

Xifin LIS 5

Xifin has launched the latest version of its lab information system, the Xifin LIS 5. The software-as-a-service-based platform includes multi-specialty workflows for molecular and next-generation sequencing. It also includes universal image management, a digital pathology consultation function, and a feature to facilitate multidisciplinary care team coordination.

Updates to the system's existing NGS module provide more specimen management, user-defined workflow steps, and the ability to support multiple lab processes. The platform's enhanced clinical trials support system now provides a project-oriented workflow. An enhanced anatomic pathology module improves the speed and functionality of new specialty workflows for gynecologic cytology, urology, and GI applications. The molecular diagnostic and genomics workflows now support FISH, gene microarray, and PCR, as well as NGS pharmacogenomics testing.

Aug 22, 2018

Sema4 NIPT and Expanded Carrier Screening Tests

Sema4 has launched a noninvasive prenatal test and an expanded carrier screening test, which it developed using its Sema4 Health Intelligence Platform. The NIPT is available in three options: a standard panel that tests for trisomies 21, 18, and 13; a standard plus panel that also includes trisomies 15, 16, and 22, as well as sex chromosome aneuploidies; and an expanded panel that includes all of the above plus some microdeletions.

The expanded carrier screen can test more than 280 genes, including 101 genes associated with Jewish founder mutations. Patients also have the option of analyzing a smaller subset of genes.

Aug 22, 2018

Seq2Know Familial Hypercholesterolemia Testing

Seq2Know has begun offering familial hypercholesterolemia testing. Its test includes the sequencing of four genes — LDLR, APOB, PCSK9, and LDLRAP1 — that cause FH. Like all of Seq2Know's tests, the FH test is ordered directly from the company and reviewed by PWNHealth, an independent physician network, for patient appropriateness. Genetic counseling is also available through PWNHealth. Seq2Know is a testing service of PreventionGenetics, a DNA testing lab offering genetic sequencing services.

Aug 22, 2018

Abreos Biosciences moNATor

Abreos Biosciences has launched its first commercial product, moNATor, a laboratory-developed test for use by physicians to monitor Tysabri (natalizumab) levels in patients with multiple sclerosis. The test is now commercially available in the US. Abreos' flagship technology is called Veritope, which identifies proprietary peptide-based ligands that can measure and purify biologic molecules. Veritope provides for the selective monitoring of therapeutic antibody drugs, allowing physicians to optimize therapeutic dose and timing. 

Pages